The European Patent Office intend to grant Brighter’s patent for AI-powered monitoring of medical devices.
The European Patent Office intend to grant Brighter’s European patent application 16744322.5 regarding Artificial Intelligence-driven medical device monitoring functionality. The patent secures rights to unique functionalities in The Benefit Loop to secure operations of medical devices. It also adds valuable functionalities to Actiste, Brighter’s unique diabetes management service, currently being introduced to the market in the United Arab Emirates, Indonesia, Thailand and Sweden. – Over the years, Brighter has built an strong IP portfolio, and we are continuously strengthening it